RankingsPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.
  3. Financials
  4. Net income

Astellas Pharma Inc.【JP:4503】

Market cap
¥4.05T
P/E ratio
22.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 202550,747+197.72%
Mar 31, 202417,045-82.73%
Mar 31, 202398,714-20.45%
Mar 31, 2022124,086+2.90%
Mar 31, 2021120,589-38.29%
Mar 31, 2020195,411-12.08%
Mar 31, 2019222,265+34.97%
Mar 31, 2018164,679-24.70%
Mar 31, 2017218,701+12.91%
Mar 31, 2016193,687+42.57%
Mar 31, 2015135,856+49.50%
Mar 31, 201490,874-1.72%
Mar 31, 201392,464+144.44%
Mar 31, 201237,827

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)